A quick update on the bivalent boosters - by Eric Topol
Eric Topol on X: "The BA.5 bivalent booster's effectiveness: by April 2023, "individuals previously vaccinated only with wild-type vaccines had little protection against Covid-19 hospital admission" restored by the booster (24K cases,
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
CDC reports on bivalent COVID-19 vaccine, Paxlovid effectiveness | AHA News
New Omicron-specific vaccines offer similar protection to existing boosters
COVID-19 bivalent booster effectiveness in people with and without immune dysfunction L
Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study - The Lancet Infectious Diseases
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
Effectiveness of Vaccination and Previous Infection Against Omicron Infection and Severe Outcomes in Children Under 12 Years of Age | medRxiv
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ
Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case-control study - The Lancet Infectious Diseases
What We Know About Getting a Second Booster Shot of COVID-19 Vaccines | The Scientist Magazine®
A quick update on the bivalent boosters - by Eric Topol
Effectiveness of Bivalent Boosters against Severe Omicron Infection | NEJM
Updated Bivalent Boosters Offer Extra Protection Against COVID-19
COVID-19 bivalent booster effectiveness in people with and without immune dysfunction L
New Omicron-specific vaccines offer similar protection to existing boosters
Potentially breaking the COVID-19 stalemate with variant booster, bivalent or polyvalent vaccines
Updated COVID-19 booster targets subvariants responsible for 98% of cases today : Oregon Health News Blog
Why payers should be preparing now for new COVID-19 boosters
